Sirolimus Is an Acceptable Alternative to Tacrolimus for Graft-versus-Host Disease Prophylaxis after Haploidentical Peripheral Blood Stem Cell Transplantation with Post-Transplantation Cyclophosphamide

Elmariah, Hany; Otoukesh, Salman; Kumar, Ambuj; Ali, Haris; Arslan, Shukaib; Shouse, Geoffrey; Pourhassan, Hoda; Nishihori, Taiga; Faramand, Rawan; Mishra, Asmita; Khimani, Farhad; Fernandez, Hugo; Lazaryan, Aleksandr; Nieder, Michael; Perez, Lia; Liu, Hien; Nakamura, Ryotaro; Pidala, Joseph; Marcucci, Guido; Forman, Stephen J.; Anasetti, Claudio; Locke, Frederick; Bejanyan, Nelli; Al Malki, Monzr M.

doi:10.1016/j.jtct.2023.11.010

Transplantation and Cellular Therapy

2024

DOI: 10.1016/j.jtct.2023.11.010

|View full text |Cite

Sirolimus Is an Acceptable Alternative to Tacrolimus for Graft-versus-Host Disease Prophylaxis after Haploidentical Peripheral Blood Stem Cell Transplantation with Post-Transplantation Cyclophosphamide

Hany Elmariah,

Salman Otoukesh,

Ambuj Kumar

et al.

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...

Citation Types

Supporting

Mentioning

Contrasting

Year Published

2024

Publication Types

Select...

Article5

Relationship

Self Cite0

Independent5

Authors

Journals

Cited by 6 publications

References 44 publications

Supporting

Mentioning

Contrasting

Order By: Relevance

Lower Weight-Based Mycophenolate Mofetil Dosing is Associated with Superior Outcomes after Haploidentical Hematopoietic Cell Transplant with Post-transplant Cyclophosphamide

Elmariah,

Otoukesh,

Kumar

et al. 2024

Transplantation and Cellular Therapy

View full text Add to dashboard Cite

Lower Weight-Based Mycophenolate Mofetil Dosing is Associated with Superior Outcomes after Haploidentical Hematopoietic Cell Transplant with Post-transplant Cyclophosphamide

Elmariah,

Otoukesh,

Kumar

et al. 2024

Transplantation and Cellular Therapy

View full text Add to dashboard Cite

Comparison of Three Graft-versus-Host Disease Prophylaxis Strategies after T Cell-Replete Haploidentical Hematopoietic Transplantation: Tacrolimus versus Calcineurin Inhibitors + Mycophenolate Mofetil versus Sirolimus + Mycophenolate Mofetil

Esquirol,

Pascual,

Montoro

et al. 2024

Transplantation and Cellular Therapy

View full text Add to dashboard Cite

Incidence, risk factors and therapy response of acute graft-versus-host disease after myeloablative hematopoietic stem cell transplantation with posttransplant cyclophosphamide

Asensi Cantó,

Gómez-Seguí,

Montoro

et al. 2024

Bone Marrow Transplant

View full text Add to dashboard Cite

scite is a Brooklyn-based organization that helps researchers better discover and understand research articles through Smart Citations–citations that display the context of the citation and describe whether the article provides supporting or contrasting evidence. scite is used by students and researchers from around the world and is funded in part by the National Science Foundation and the National Institute on Drug Abuse of the National Institutes of Health.

Contact Info

customersupport@researchsolutions.com

10624 S. Eastern Ave., Ste. A-614

Henderson, NV 89052, USA

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

Blog Terms and Conditions API Terms Privacy Policy Contact Cookie Preferences Do Not Sell or Share My Personal Information

Made with 💙 for researchers

Part of the Research Solutions Family.

Sirolimus Is an Acceptable Alternative to Tacrolimus for Graft-versus-Host Disease Prophylaxis after Haploidentical Peripheral Blood Stem Cell Transplantation with Post-Transplantation Cyclophosphamide

Cited by 6 publications

References 44 publications

Lower Weight-Based Mycophenolate Mofetil Dosing is Associated with Superior Outcomes after Haploidentical Hematopoietic Cell Transplant with Post-transplant Cyclophosphamide

Lower Weight-Based Mycophenolate Mofetil Dosing is Associated with Superior Outcomes after Haploidentical Hematopoietic Cell Transplant with Post-transplant Cyclophosphamide

Comparison of Three Graft-versus-Host Disease Prophylaxis Strategies after T Cell-Replete Haploidentical Hematopoietic Transplantation: Tacrolimus versus Calcineurin Inhibitors + Mycophenolate Mofetil versus Sirolimus + Mycophenolate Mofetil

Incidence, risk factors and therapy response of acute graft-versus-host disease after myeloablative hematopoietic stem cell transplantation with posttransplant cyclophosphamide

Contact Info

Product

Resources

About